ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q1SCImago #5,365Hybrid

International Journal of Clinical Oncology

Acronym:ijco
•
Abbreviation (ISO):INT J CLIN ONCOL
•
Identifier (ISSN):1341-9625(Print)/1437-7772(Online)
•
Publisher:Springer Singapore
Clarivate IF (2026)
3↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for International Journal of Clinical Oncology

WoS Q3
12452.6120182.520192.8820203.420213.8520223.320232.420242.8202532026
Annual Impact Factor Metric
Current (2026):3
Scopus SJR & RankScopus Q1
0.945
#5,365

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
83

83 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
239articles/year
29.22% Gold OA•86.49% Original Research

Aims & Scope

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

Topics Covered (Recognized by AI)
Medicine99.8%Internal medicine98.9%Biology95.8%Surgery92.6%Genetics91.5%Oncology87.1%Cancer77.8%Surgical oncology73.4%Pathology70.1%Radiology39.1%Chemistry35.2%Chemotherapy35%Immunology27.8%Mathematics27%Biochemistry26.2%Gastroenterology22.9%Statistics22.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q3
Rank172/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank177/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3
Articles / Year246
Total Citations65
2025
IF2.8
Articles / Year265
Total Citations675
2024
IF2.4
Articles / Year230
Total Citations1,322
2023
IF3.3
Articles / Year162
Total Citations1,433
2022
IF3.85
Articles / Year196
Total Citations2,376

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,365Scopus Q1SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
0.945

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
2.99

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,286 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,778
3-Year Documents587
Citable Documents580

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate19.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
SurgeryQ1
HematologyQ2
OncologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

International Journal of Clinical Oncology (acronym: ijco, abbr: INT J CLIN ONCOL, ISSN: 1341-9625) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Singapore in Japan since 1996. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.945 (Q1), an H-index of 83.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 239 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,286 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Singapore
Publication Language
English
Frequency
Bimonthly
Founding Year
1996
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER TOKYO, 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, JAPAN, 102-0073

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a6934aa3-e91d-49dc-9595-b93f05b65261
Database Updated: 2026-09-28